NMPA Approval

Mercaptopurine Tablets

Approval Number

国药准字H11021699

Company华润双鹤药业股份有限公司

Registration Date

September 27, 2023

Drug Information

Generic Name

巯嘌呤片

Dosage Form

片剂

Strength

50mg

Drug Type

化学药品

Registration Date

September 27, 2023

Company Information

Applicant Company

Company Name华润双鹤药业股份有限公司

Company Address

北京市朝阳区望京利泽东二路1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.